TSBX - Turnstone Biologics Corp
IEX Last Trade
0.7028
0.009 1.252%
Share volume: 159,361
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.01
1.27%
View ratios
| Fiscal Date | 2024-03-31 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 2024-05-13 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 20.691 M | |
| Selling general and admin | 4.901 M | |
| Research and development | 15.790 M | |
| Total expenses | 20.691 M | |
| Operating income | -20.691 M | |
| Ebit | -20.691 M | |
| Pretax income | -19.613 M | |
| Income tax | 16.000 K | |
| Net income basic | -19.629 M | |
| Net income | -19.629 M | |